MTUSD:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF USD Capitalisation (USD)

ETF | Others |

Last Closing

USD 9.7419

Change

+0.06 (+0.59)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.17 (+0.37%)

USD 61.38B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-4.50 (-0.78%)

USD 13.43B
WRD:PA HSBC MSCI World UCITS ETF

-0.28 (-0.75%)

USD 11.05B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-3.86 (-0.93%)

USD 9.62B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-7.30 (-1.43%)

USD 8.88B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.19 (+0.08%)

USD 8.55B
HHH:PA HSBC S&P 500 UCITS ETF

-0.53 (-0.91%)

USD 7.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.66 (-0.74%)

USD 7.63B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.13 (-0.70%)

USD 6.83B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-1.71 (-1.03%)

USD 5.48B

ETFs Containing MTUSD:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.70% 36% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.70% 36% F 39% F
Trailing 12 Months  
Capital Gain -0.88% 8% B- 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.88% 8% B- 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.50% 27% F 41% F
Dividend Return 2.50% 25% F 39% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.15% 86% B+ 93% A
Risk Adjusted Return 48.60% 34% F 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.